Who owns SILENCE THERAPEUTICS PLC?

Tip: Access positions for across all investors

Analyze quarterly positions in Silence Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Silence Therapeutics stock

Who bought or sold SILENCE THERAPEUTICS PLC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
TCG Crossover Management 3.0M $16M 0% Mar 2026
 View chart
Siren 2.9M $15M 0% Mar 2026
 View chart
Redmile Group 2.2M $11M 0% Mar 2026
 View chart
Nantahala Capital Management 2.1M $11M 39% Mar 2026
 View chart
Citadel Advisors 1.2M $6.6M 381% Mar 2026
 View chart
Millennium Management 1.1M $5.7M 63% Mar 2026
 View chart
Dr. Jeffrey R. Jay, M.D. 1.0M $5.4M 26% Mar 2026
 View chart
Nextech Invest 952k $5.0M 0% Mar 2026
 View chart
Ikarian Capital 866k $1.7M 0% Mar 2026
 View chart
Polygon Management 630k $3.3M 72% Mar 2026
 View chart
5AM Venture Management 476k $2.5M 0% Mar 2026
 View chart
Jones Hill Capital 302k $1.6M 100% Mar 2026
 View chart
SG Americas Securities 287k $1.5M 12% Mar 2026
 View chart
UBS Group 247k $1.3M 19% Mar 2026
 View chart
Boothbay Fund Management 209k $1.1M 0% Mar 2026
 View chart
BlackRock 205k $1.1M 180% Mar 2026
 View chart
Bank Of Montreal 203k $1.1M 100% Mar 2026
 View chart
ADAR1 Capital Management 172k $907k 628% Mar 2026
 View chart
Marshall Wace 170k $894k 9% Mar 2026
 View chart
Seven Fleet Capital Management 157k $826k 6% Mar 2026
 View chart
Susquehanna International 154k $814k 269% Mar 2026
 View chart
Bnp Paribas Arbitrage, Snc 148k $778k 1128% Mar 2026
 View chart
Hsbc Holdings 123k $640k -29% Mar 2026
 View chart
Point72 Asset Management 120k $631k 5% Mar 2026
 View chart
XTX Topco 106k $559k 805% Mar 2026
 View chart
Qube Research & Technologies 105k $551k 199% Mar 2026
 View chart
M28 Capital Management 101k $533k -45% Mar 2026
 View chart
Jane Street 101k $532k 246% Mar 2026
 View chart
Squarepoint Ops 90k $472k 100% Mar 2026
 View chart
Morgan Stanley 66k $345k -80% Mar 2026
 View chart
Goldman Sachs Group 53k $277k 190% Mar 2026
 View chart
Bank of America Corporation 30k $157k 100% Mar 2026
 View chart
Geode Capital Management 30k $156k 0% Mar 2026
 View chart
Raymond James Financial 25k $132k 0% Mar 2026
 View chart
Two Sigma Investments 16k $85k -59% Mar 2026
 View chart
Rhumbline Advisers 14k $73k 7% Mar 2026
 View chart
Hrt Financial 12k $63k 100% Mar 2026
 View chart
GAMMA Investing 11k $122k 18% Jun 2026
 View chart
Dynamic Technology Lab Private 11k $55k 100% Mar 2026
 View chart
China Universal Asset Management 7.5k $82k -10% Jun 2026
 View chart
Acadian Asset Management 4.8k $25k 100% Mar 2026
 View chart
Barclays 2.9k $16k -42% Mar 2026
 View chart
Jones Financial Companies, L.L 2.5k $12k 0% Mar 2026
 View chart
Mirae Asset Global Investments 2.5k $13k 7% Mar 2026
 View chart
Tower Research Capital 2.3k $12k -6% Mar 2026
 View chart
Citigroup 1.8k $9.7k 100% Mar 2026
 View chart
Parallel Advisors 1.3k $6.9k 0% Mar 2026
 View chart
Gf Fund Management 1.0k $5.5k 14% Mar 2026
 View chart
Simplex Trading 612.00 $3.2k -85% Mar 2026
 View chart
Steward Partners Investment Advisory 100.00 $527.000000 0% Mar 2026
 View chart
Rockefeller Capital Management 45.00 $237.001500 0% Mar 2026
 View chart
SBI Securities 28.00 $147.999600 0% Mar 2026
 View chart
Royal Bank of Canada 16.00 $0 100% Mar 2026
 View chart
Caitong International Asset Management 3.00 $15.999900 100% Mar 2026
 View chart

Who sold out of Silence Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Vivo Capital Dec 2025 1.1M $6.7M
Lombard Odier Asset Management Dec 2025 256k $1.2M
Opaleye Management Dec 2025 79k $480k
Quadrature Capital Dec 2025 54k $331k
Two Sigma Advisers Dec 2025 16k $97k
Advisor Group Holdings Dec 2025 3.00 $18.000000